First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus.

The concentrations of maternal serum markers for aneuploidy screening are influenced by maternal characteristics such as race, smoking, insulin dependent diabetes mellitus (IDDM), and in vitro fertilization (IVF). Accurate risk estimation requires adjustment of initial values for these characteristics. This study aims to update and validate adjustment factors for race, smoking, and IDDM. 

Clin Biochem. 2023 118:110596. doi: 10.1016/j.clinbiochem.2023.110596. 

Contact Us

Prenatal Screening Ontario 
CHEO Research Institute 
Centre for Practice-Changing Research Building 
401 Smyth Road 
Ottawa, ON K1H 8L1

pso@bornontario.ca

Information line
Phone: 613-737-2281
Toll-Free: 1-833-351-6490

Monday to Friday, 9:00 AM to 3:00 PM EST

Subscribe to PSO Updates

Subscribe to stay informed about the latest PSO news and prenatal screening updates in Ontario.
Virtual educational sessions on prenatal screening and nuchal translucency quality assurance are available upon request for health‑care providers.